Skip to content

HVN Medicine

Active Private limited companyfounded 2023active for 3 yearsAvenue des Dauphins 27, 1470 GenappeKBO/BCE: BE 0795.742.567

Lifetime

3 annual accounts with figures on one time axis
peak of €121,579 in 2024
€119,012▼ 2.1%
peak of €91,148 in 2025
€91,148▲ 6.1%
peak of €152,612 in 2024
€107,362▼ 29.7%
€176,344▲ 185%
Board1 name since 2023
1 director
Documentsfilings and deeds
27-07-20264 days before the deadline
2025micro format
Dividend €136,397Equity from €152,612 to €107,362Debts from €61,898 to €176,344Cash from €192,446 to €268,778

Key points

from the 2025 annual accounts

Equity

€107,362 ▼ 29.7%
152,6122024+91,148Profit-136,397Dividend107,3622025

HVN Medicine paid out €136,397 in dividends. That is 150% of the 2025 profit.

Turnover

≈ €300,000 estimated

The micro format states no turnover.

Debts

€176,344 ▲ 185%
Other debts
+100,000
Taxes and wages
+15,820
Suppliers
+1,085
The rest
-2,458

Debts rose by €114,447 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Liquidity

1.53 was 3.25 in 2024

Short-term debts rose from €59,439 to €176,344.

Filings

3 annual accounts 1 late
AprilJune31 JulyOctober202320242025

The 2024 accounts came 26 days late. The other two were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as HVN Medicine has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for HVN Medicine. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 04-01-2023
  • 100 sharesdeed of 06-01-2023
Board & ownership

Recent changes

Registered office moved from Brussels to Baisy-Thy The registered office moved from Auderghem (1160 Bruxelles), avenue de Beaulieu 10 boîte 3 to avenue des Dauphins 27, 1470 Baisy-Thy · Board meeting of 02-11-2025 · Gazette deed
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 06-01-2023 · Gazette deed
First establishment Rue Wayez 35, Braine-l'Alleud
All 8 events

Official details

Source: KBO
Status
Active since 04-01-2023Normal situation
Activity
“En assurant l’exploitation et la gestion d'un centre médical ou d'un cabinet médical, en…” (deed in French)From the articles, 8 activities1 activity on the establishment unit
Establishment unit
2.340.384.4251420 Braine-l'Alleud, since 04-01-2023
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€283,707▲ 32.3%
Filing
Filed on 27-07-2026, 4 days before the end of the filing period
Financials

Insights on HVN Medicine

HVN Medicine files the micro format. That format states no turnover. The gross margin rose from €100,631 in 2023 to €119,012 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about HVN Medicine

What is the company number of HVN Medicine?
The company number of HVN Medicine is 0795.742.567. The VAT number is the same number with BE in front: BE 0795.742.567.
Where is HVN Medicine based?
The registered office is at Avenue des Dauphins 27, 1470 Genappe.Company details
What is the legal form of HVN Medicine?
HVN Medicine is a private limited company (BV).
When was HVN Medicine founded?
HVN Medicine was founded on 04-01-2023.
Is HVN Medicine still active?
Yes, HVN Medicine is an active enterprise in the KBO register.
What is the turnover of HVN Medicine?
The turnover in financial year 2025 is ≈ €300,000. This figure is estimated from the gross margin of €119,012 and 2,459 comparable companies of the same size. It probably lies between €200,000 and €460,000. It is a rough estimate.Financials
Is HVN Medicine profitable?
In financial year 2025, HVN Medicine made a profit of €91,148.
Where can I find the annual accounts of HVN Medicine?
HVN Medicine filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of HVN Medicine due?
HVN Medicine must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.